Skip to main content
TipRanks
Go Ultimate75% OFF

John Duncan Higgons Insider Profile

4 Followers

John Duncan Higgons, COO at Agios Pharma, holds 9.71K shares in Jounce Therapeutics (Ticker: JNCE), holds 120.83K shares in Agios Pharma (Ticker: AGIO).

John Duncan Higgons's Trading History

JNCE
Jounce Therapeutics
Apr 16, 2021―Uninformative Sell2.00K$18.26K
AGIO
Agios Pharma
Jan 05, 2016COOUninformative Buy195.93K$3.64M

You May Also Like

John Duncan Higgons insider profile FAQ

What is the percentage of profitable transactions made by John Duncan Higgons?
The percentage of profitable transactions made by John Duncan Higgons is 33%.
What is the average return per transaction made by John Duncan Higgons?
The average return per transaction made by John Duncan Higgons is 14.30%.
What stocks does John Duncan Higgons hold?
John Duncan Higgons holds: AGIO, JNCE stocks.
What was John Duncan Higgons’s latest transaction?
John Duncan Higgons’s latest transaction was an Uninformative Sell of $2.00K.
What was John Duncan Higgons's most profitable transaction?
John Duncan Higgons’s most profitable transaction was an Informative Buy of AGIO stock on March 12, 2014. The return on the trade was 147.60%.
What is John Duncan Higgons's role in Agios Pharma?
John Duncan Higgons's role in Agios Pharma is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.